ACM Biolabs

ACM Biolabs is an innovative company spin-off from Nanyang Technological University in Singapore, dedicated to developing highly efficient delivery systems for various vaccines and innovative drugs. It possesses the "artificial cell membrane" system platform delivery technology, which can significantly enhance the immune effects of human and veterinary vaccines and transform the delivery pathways of peptide-based drugs. ACM Biolabs' novel polymer platform has a mature synthesis route, simple formulation process, minimal quality control challenges, and can easily achieve industrialization under cGMP conditions. As a new type of vaccine adjuvant and delivery system, it has broad application prospects.